# Launch One Acquisition Corp. (LPAAW) — merger/spac_merger [terminated]
Source: SEC API (secapi.ai) · situation sit_34ee5dde645c7f4e2942 · retrieved 2026-08-12T21:18:59.612Z

## Overview
Launch One Acquisition Corp. is a blank-check company (SPAC) incorporated in the Cayman Islands and listed on Nasdaq, seeking to effect a business combination.

Launch One Acquisition Corp. (a SPAC) terminated its Business Combination Agreement with Minovia Therapeutics Ltd., dated June 25, 2025 and amended multiple times through January 6, 2026, effective January 30, 2026. Under the original agreement, Minovia would have merged with a subsidiary of Pubco (Mito US One Ltd.), with Minovia shareholders receiving ordinary shares of Pubco and the SPAC subsequently merging into Pubco to create a publicly traded company. The parties executed a Termination and Release Agreement on January 30, 2026, mutually releasing each other from all liabilities and damages relating to the transaction documents and proposed transactions. The Company and its sponsor currently intend to seek alternative ways to consummate an initial business combination.

## Terms
- Counterparty: Minovia Therapeutics Ltd.

## Key dates
- Announced 2026-01-13 · Terminated 2026-02-04

## Timeline
- 2026-01-13 · 425 (0001213900-26-003787): 425 - Launch One Acquisition Corp. — *Minovia Therapeutics is a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, with its lead program MNV-201 consisting of autologous hematopoietic stem cells enriched with placental-derived mitochondria.* Minovia Therapeutics Ltd., a clinical-stage biotechnology company developing mitochondrial augmentation therapies, has entered into a definitive business combination agreement with Launch One Acquisition Corp. (Nasdaq: LPAA), a publicly traded special purpose acquisition company. The transaction is expected to close in the first half of 2026, following which the combined company will operate as Minovia Therapeutics and trade on Nasdaq under a new ticker symbol.
  https://www.sec.gov/Archives/edgar/data/2015502/0001213900-26-003787.txt
- 2026-02-04 · 425 (0001213900-26-011729): 425 - Launch One Acquisition Corp. — *Launch One Acquisition Corp. is a blank-check company (SPAC) incorporated in the Cayman Islands and listed on Nasdaq, seeking to effect a business combination.* Launch One Acquisition Corp. (a SPAC) terminated its Business Combination Agreement with Minovia Therapeutics Ltd., dated June 25, 2025 and amended multiple times through January 6, 2026, effective January 30, 2026. Under the original agreement, Minovia would have merged with a subsidiary of Pubco (Mito US One Ltd.), with Minovia shareholders receiving ordinary shares of Pubco and the SPAC subsequently merging into Pubco to create a publicly traded company. The parties executed a Termination and Release Agreement on January 30, 2026, mutually releasing each other from all liabilities and damages relating to the transaction documents and proposed transactions. The Company and its sponsor currently intend to seek alternative ways to consummate an initial business combination.
  https://www.sec.gov/Archives/edgar/data/2015502/0001213900-26-011729.txt
- 2026-02-04 · 8-K (0001213900-26-011726): 8-K CURRENT REPORT
  https://www.sec.gov/Archives/edgar/data/2015502/000121390026011726/ea0275409-8k425_launchone.htm

## Citations
- 0001213900-26-003787 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026003787
- 0001213900-26-011729 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026011729
- 0001213900-26-011726 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026011726